Enlivex Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITIZENS FINANCIAL GROUP INC/RI | 10/24/2025 | 231.42 K | $240.68 K | 100.00% | 0.97% |
| MORGAN STANLEY | 11/14/2025 | 173.63 K | $180.57 K | -20.77% | 0.73% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 157.29 K | $163.58 K | -6.59% | 0.66% |
| CITADEL ADVISORS LLC | 11/14/2025 | 68.94 K | $71.69 K | 100.00% | 0.29% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 54.85 K | $57.04 K | 100.00% | 0.23% |
| XTX TOPCO LTD | 11/14/2025 | 42.67 K | $44.38 K | 100.00% | 0.18% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 34.24 K | $35.61 K | 100.00% | 0.14% |
| SIGMA INVESTMENT COUNSELORS INC | 10/29/2025 | 28.00 K | $29.12 K | 0.00% | 0.12% |
| JANE STREET GROUP, LLC | 11/14/2025 | 21.53 K | $22.39 K | -64.74% | 0.09% |
| HRT FINANCIAL LP | 11/14/2025 | 18.79 K | $19.00 K | 100.00% | 0.08% |
| PROSPERITY CONSULTING GROUP, LLC | 11/14/2025 | 17.65 K | $18.35 K | 100.00% | 0.07% |
| NEUBERGER BERMAN GROUP LLC | 11/12/2025 | 10.99 K | $11.43 K | 0.00% | 0.05% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 10.74 K | $11.17 K | 100.00% | 0.05% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 9.18 K | $9.55 K | 0.00% | 0.04% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 7.00 K | $7.28 K | 0.00% | 0.03% |
| SIGNATUREFD, LLC | 10/21/2025 | 5.00 K | $5.20 K | 0.00% | 0.02% |
| UBS GROUP AG | 11/13/2025 | 4.04 K | $4.20 K | 100.00% | 0.02% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/12/2025 | 2.50 K | $2.60 K | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 2.13 K | $2.22 K | -70.18% | 0.01% |
| SRS CAPITAL ADVISORS, INC. | 11/14/2025 | 1.02 K | $1.06 K | 0.00% | 0.00% |
| BFSG, LLC | 10/29/2025 | 1.00 K | $1.04 K | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 11/03/2025 | 1.00 K | $1.04 K | 0.00% | 0.00% |
| SPIRE WEALTH MANAGEMENT | 10/23/2025 | 500 | $520 | 0.00% | 0.00% |
| RED TORTOISE LLC | 10/22/2025 | 150 | $156 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 125 | $130 | -95.89% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 100 | $104 | -94.49% | 0.00% |
| ADVISORY SERVICES NETWORK, LLC | 11/18/2025 | 43 | $45 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 1 | $1 | 100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enlivex Therapeutics Ltd. institutional Ownership - FAQ's
During the previous two years, 35 institutional investors and hedge funds held shares of Enlivex Therapeutics Ltd.. The most heavily invested institutionals were:
CITIZENS FINANCIAL GROUP INC/RI: 231,424
MORGAN STANLEY: 173,625
RENAISSANCE TECHNOLOGIES LLC: 157,292
CITADEL ADVISORS LLC: 68,936
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 54,850
XTX Topco Ltd: 42,668
3.79% of Enlivex Therapeutics Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 929.54 K shares in the last 24 months. This purchase volume represents approximately $985.31 K in transactions.